Skip to content

Aurinia Pharmaceuticals Inc.

AUPH

CIK 0001600620

← back to feed
Revenue (TTM)
$283.65M
+5.0% YoY Q1 May 2026
Net Income (TTM)
$110.76M
+568.1% YoY Q1 May 2026
EPS Diluted (TTM)
$0.80
+565.2% YoY Q1 May 2026
Gross Margin
89.3%
Q1 May 2026
Operating Margin
39.9%
Q1 May 2026
Net Margin
39.0%
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$40.75M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
128.6M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings